The potential of targeting Wnt/β-catenin in colon cancer

Expert Opinion on Therapeutic Targets

Volumn 18, Issue 6, 2014, Pages 611-615

  Sebio, Ana ^a   Kahn, Michael ^a   Lenz, Heinz Josef ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Colorectal cancer; Inhibitor; Therapeutics; Wnt catenin

Indexed keywords

2,4 DIAMINOQUINAZOLINE DERIVATIVE; 3 INDOLEMETHANOL; 3,3' DIINDOLYLMETHANE; ACETYLSALICYLIC ACID; ANTINEOPLASTIC AGENT; BETA CATENIN; CELECOXIB; CGP 049090; CWP 232291; FJ 9; FOXY 5; G 007LK; G007 LK; GENISTEIN; JW 55; LGK 974; LYCOPENE; MAGNOLOL; NATURAL PRODUCT; NONSTEROID ANTIINFLAMMATORY AGENT; NSC 668036; OMP 18R 5; OMP 54F 28; OMP 54F28; OTSA 101; PKF 115 584; PNU 74654; PRI 724; SULINDAC; UNCLASSIFIED DRUG; VANTICTUMAB; WNT PROTEIN; CTNNB1 PROTEIN, HUMAN;

ANTINEOPLASTIC ACTIVITY; CANCER PATIENT; CELL DIFFERENTIATION; COLON CARCINOGENESIS; COLORECTAL CANCER; DRUG TARGETING; EPITHELIAL MESENCHYMAL TRANSITION; GENE MUTATION; HUMAN; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; ANTAGONISTS AND INHIBITORS; COLONIC NEOPLASMS; DRUG EFFECTS; MOLECULARLY TARGETED THERAPY; PHYSIOLOGY; WNT SIGNALING PATHWAY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETA CATENIN; COLONIC NEOPLASMS; HUMANS; MOLECULAR TARGETED THERAPY; WNT SIGNALING PATHWAY;

EID: 84900796850     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2014.906580     Document Type: Review

References (15)

1. Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012;487:330-7
2. Wanitsuwan W, Kanngurn S, Boonpipattanapong T, et al. Overall expression of beta-catenin outperforms its nuclear accumulation in predicting outcomes of colorectal cancers. World J Gastroenterol 2008;14:6052-9
3. Baldus SE, Monig SP, Huxel S, et al. MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis. Clin Cancer Res 2004;10:2790-6
4. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature 2005;434:843-50
5. Yang AD, Fan F, Camp ER, et al. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res 2006;12:4147-53
6. Kahn M. Symmetric division versus asymmetric division: a tale of two coactivators. Future Med Chem 2011;3:1745-63
7. Palmer HG, Gonzalez-Sancho JM, Espada J, et al. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 2001;154:369-87
8. Xiao JH, Ghosn C, Hinchman C, et al. Adenomatous polyposis coli (APC)-independent regulation of beta-catenin degradation via a retinoid X receptor-mediated pathway. J Biol Chem 2003;278:29954-62
9. Sarkar FH, Li Y, Wang Z, et al. The role of nutraceuticals in the regulation of Wnt and Hedgehog signaling in cancer. Cancer Metastasis Rev 2010;29:383-94
10. Takahashi-Yanaga F, Taba Y, Miwa Y, et al. Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3beta and degrades cyclin D1 in mammalian cells. J Biol Chem 2003;278:9663-70
11. Su Y, Simmen RC. Soy isoflavone genistein upregulates epithelial adhesion molecule E-cadherin expression and attenuates beta-catenin signaling in mammary epithelial cells. Carcinogenesis 2009;30:331-9
12. Hwang JT, Ha J, Park OJ. Combination of 5-fluorouracil and genistein induces apoptosis synergistically in chemo-resistant cancer cells through the modulation of AMPK and COX-2 signaling pathways. Biochem Biophys Res Commun 2005;332:433-40
13. Ma H, Nguyen C, Lee KS, et al. Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression. Oncogene 2005;24:3619-31
14. El-Khoueiry AB, Ning Y, Yang D, et al. A phase I first-in-human study of PRI-724 in patients (pts) with advanced solid tumors. J Clin Oncol 2013;31(Suppl):abstract 2501
15. Topol L, Jiang X, Choi H, et al. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol 2003;162:899-908